PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2001 December; 2(4): 86–92.
Published online 2015 February 19. doi:  10.1007/BF02830570
PMCID: PMC2784845

Effect of additives on the release of a model protein from PLGA microspheres

Abstract

The purpose of this study was to investigate the effect of 2 additives, poly(ethylene glycol (PEG) 1000 and 1,2,3-tridecanoyl glycerol (tricaprin), on the physico-chemical characteristics and in vitro release of a model protein, bovine serum albumin (BSA), form poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres. BSA-loaded microspheres were prepared by the double emulsion solvent evaporation method. Additives were incorporated into microspheres to modify the release of protein. The addition of PEG 1000 and tricaprin changed the surface characteristics of microspheres from smooth and nonporous to porous and dimpled, respectively. The in vitro release profiles showed that the additives significantly (P<0.05) increased the early-stage release of BSA from microspheres.

Keywords: microspheres, poly(D,L-lactic-co-glycolic acid), bovine serum albumin, poly(ethylene glycol), tricaprin, morphology, and in vitro release

Full Text

The Full Text of this article is available as a PDF (2.6M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Talmadge JE. The pharmaceutics and delivery of therapeutic polypeptides and proteins. Adv Drug Del Rev. 1993;10:247–299. doi: 10.1016/0169-409X(93)90049-A. [Cross Ref]
2. Sanders LM. Drug delivery systems and routes of administration of peptide and protein drugs. Eur J Drug Metab Pharmacokinet. 1990;15:95–102. doi: 10.1007/BF03190192. [PubMed] [Cross Ref]
3. Mehta RC, Thanoo BC, DeLuca PP. Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide) J Control Release. 1996;41:249–257. doi: 10.1016/0168-3659(96)01332-6. [Cross Ref]
4. Chiba M, Hanes J, Langer R. Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres. Biomaterials. 1997;18:893–901. doi: 10.1016/S0142-9612(97)00027-6. [PubMed] [Cross Ref]
5. Ravivarapu HB, Burton K, DeLuca PP. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Eur J Pharm Biopharm. 2000;50:263–270. doi: 10.1016/S0939-6411(00)00099-0. [PubMed] [Cross Ref]
6. Hausberger AG, DeLuca PP. Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres. J Pharm Biomed Anal. 1995;13:747–760. doi: 10.1016/0731-7085(95)01276-Q. [PubMed] [Cross Ref]
7. Kostanski JW, DeLuca PP. A novel in vitro release technique for peptide-containing biodegradable microspheres. AAPS PharmSciTech [serial online]. 2000; 1(1) article 4. Available at: http://www.pharmscitech.com. [PMC free article] [PubMed]
8. Smith KL, Schimpf AE, Thompson KE, Yang YY, Chung TS, Ng NP. Biodegradable polymers for delivery of macromolecules. Adv Drug Del Rev. 1990;4:343–357. doi: 10.1016/0169-409X(90)90026-O. [Cross Ref]
10. Sansdrap P, Mo AJ. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres. J Microencapsul. 1998;15:545–553. doi: 10.3109/02652049809008239. [PubMed] [Cross Ref]
11. Schaefer MJ, Singh J. Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres. AAPS PharmSciTech [serial online]. 2000;1(4) article 32: Available at: http://www.pharmscitech.com. [PMC free article] [PubMed]
12. Cleek RL, Ting KC, Eskin SG, Mikos AG. Microparticles of poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery. J Control Release. 1997;48:259–268. doi: 10.1016/S0168-3659(97)00052-7. [Cross Ref]
13. Lavell EC, Yeh MK, Coombes AGA, Davis SS. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microspheres based on blends of lactide polymers and polyethylene glycol. Vaccine. 1999;17:512–529. doi: 10.1016/S0264-410X(98)00229-1. [PubMed] [Cross Ref]
14. Jiang W, Schwendeman SP. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D,L-lactide) and poly(ethylene glycol) microsphere blends. Pharm Res. 2001;18:878–885. doi: 10.1023/A:1011009117586. [PubMed] [Cross Ref]
15. Wang YM, Sato H, Horikoshi I. In vitro and in vivo evaluation of toxal release from poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres. J Control Release. 1997;49:157–166. doi: 10.1016/S0168-3659(97)00082-5. [Cross Ref]
16. Juni K, Ogata J, Matsui N, Kubota M, Nakano M. Modification of the release rate of aclarubicin from polylactic acid microspheres by using additives. Chem Pharm Bull. 1985;33:1734–1738. doi: 10.1248/cpb.33.1734. [PubMed] [Cross Ref]
17. Schaefer MJ, Singh J. Release kinetics of etoposide from PLGA microspheres. Paper presented at 26th International Symposium on Controlled Release of Bioactive Materials; June 20–25, 1999; Boston, MA.
18. Singh J, Schaefer MJ. Polymer degradation and release of etoposide. Paper presented at: 27th International Symposium on Controlled Release of Bioactive Materials; July 7–13, 2000, Paris, France.
19. Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res. 1991;8:713–720. doi: 10.1023/A:1015841715384. [PubMed] [Cross Ref]
20. Shibuya T, Watanade Y, Nalley KA, Fusco A, Salafsky B. The BCA protein determination system: an analysis of several buffers, incubation temperature and protein standards. J Tokyo Mid College. 1989;47:677–682.
21. Sanders LM, Kell BA, McRae GI, Whitehead GW. Prolonged controlled-release of narfarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer. J Pharm Sci. 1986;75:356–360. doi: 10.1002/jps.2600750407. [PubMed] [Cross Ref]
22. Brodbeck KJ, DesNoyer JR, McHugh AJ. Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. J Control Release. 1999;62:333–344. doi: 10.1016/S0168-3659(99)00159-5. [PubMed] [Cross Ref]
23. Kim H, Park TG. Stability problems and incomplete release mechanism of human growth hormone encapsulated within poly(D,L-lactic-co-glycolic acid) microspheres prepared by double emulsion method. Biotechnol Bioeng. 1999;65:659–667. doi: 10.1002/(SICI)1097-0290(19991220)65:6<659::AID-BIT6>3.0.CO;2-9. [PubMed] [Cross Ref]
24. Morita T, Horikiri Y, Suzuki T, Yoshino H. Applicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoir-type microspheres. Eur J Pharm Biopharm. 2001;51:45–53. doi: 10.1016/S0939-6411(00)00138-7. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists